Repare Therapeutics doses first subject in Phase I solid tumour trial

Retrieved on: 2024-10-14 17:38:55

Tags for this article:

Click the tags to see associated articles and topics

Repare Therapeutics doses first subject in Phase I solid tumour trial. View article details on hiswai:

Excerpt

The gold standard of business intelligence. Find out more. Related Company Profiles. Repare Therapeutics Inc · View all. The open-label, multicentre ...

Article found on: www.clinicaltrialsarena.com

View Original Article